Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-22-055334
Filing Date
2022-09-12
Accepted
2022-09-12 16:35:18
Documents
1
Period of Report
2022-09-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4.html 4  
1 PRIMARY DOCUMENT doc4.xml 4 19638
  Complete submission text file 0001213900-22-055334.txt   20942
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Issuer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address
Tomsche David Scott (Reporting) CIK: 0001384044 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12934 | Film No.: 221238956